Pulse Medical Imaging Technology (Shanghai) Co., Ltd, is founded in 2015, located in Shanghai, China, is dedicated to develop innovative technology for precise diagnosis and optimal treatment of patients with coronary artery disease.

 

Together with our R&D partners, eg., Shanghai Jiao Tong University, Oxford University, Aarhus University Hospital, Fuwai Hospital, CAMS (Chinese Academy of Medical Sciences), Zhongshan Hospital affiliated to Fudan University, Pulse Medical has been pioneering invented the key algorithm of quantitative flow ratio (QFR), the fast computation methodology of fractional flow reserve (FFR) from multiple imaging data.

 

The computed tomography based FFR (CT-QFR), angiography-based FFR (QFR in first generation, μFR in 2nd generation) and intracoronary IVUS or OCT-based FFR (UFR, OFR) have commercialized in China and Europe.

 

Our mission is to deliver the innovative and valuable solutions that could improve patient outcomes.